Colossal Biosciences: de-extinction may help extend human life

Colossal Biosciences has created three genetically engineered dire wolf pups and is working on the woolly mammoth, dodo and Tasmanian tiger. The company is valued at $10.2 billion after a $200 million Series C round, and its CRISPR and DNA synthesis work could feed into human healthcare and gene therapies.

• Colossal produced three dire wolf pups: Romulus, Remus and Khaleesi
• The genome was reconstructed from DNA in a centuries-old skull and tooth
• A $200 million Series C round lifted the company's valuation to $10.2 billion
• A woolly mammoth birth is targeted for the 2030s